SPARC   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Mumbai India (2006)

Organization Overview

First Clinical Trial
2008
NCT03055143
First Marketed Drug
2018
levetiracetam (keppra)
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

SPARC | Sun Pharma Advanced Research Centre Ltd,India | Sun Pharma Advanced Research Company Limited